Benjamin Ajibade | Nursing and Health Professions | Innovative Research Award

Innovative Research Award

Benjamin Ajibade
Northumbria University, United Kingdom
Benjamin Ajibade
Affiliation Northumbria University
Country United Kingdom
Scopus ID 57355622100
Documents 12
Citations 48
h-index 3
Subject Area Nursing and Health Professions
Event Top Teachers Awards
ORCID 0000-0002-0204-4205
Google Scholar MiIjB38AAAAJ

Benjamin Ajibade is a mental health nursing academic, researcher, educator, and institutional leader affiliated with Northumbria University in the United Kingdom. His academic profile combines extensive clinical nursing experience, higher education leadership, doctoral supervision, curriculum innovation, inclusive teaching practice, and interdisciplinary research. His scholarly contributions have focused on nursing education, mental health, equity and inclusion, international student experiences, healthcare access, dementia care, and culturally responsive educational methodologies including LEGO® Serious Play®.[1]

With more than three decades of combined clinical and academic experience, Benjamin Ajibade has contributed to nursing scholarship through peer-reviewed publications, conference presentations, research supervision, editorial service, external examining activities, grant-funded projects, and leadership of initiatives aimed at widening participation and advancing equity within higher education and healthcare systems.[1]

Abstract

This article presents an academic overview of Benjamin Ajibade’s professional achievements, scholarly contributions, educational leadership, research supervision, community engagement, and service to nursing education. Particular attention is given to his work in mental health nursing, inclusion and diversity initiatives, international student transition research, doctoral supervision, curriculum innovation, and externally funded projects. The profile also evaluates his suitability for recognition through the Innovative Research Award associated with the Top Teachers Awards based on documented evidence of academic leadership, research activity, educational innovation, and professional impact.[1]

Keywords

Mental Health Nursing; Nursing Education; Higher Education; Inclusivity; Equity and Diversity; LEGO® Serious Play®; Doctoral Supervision; Curriculum Development; Healthcare Research; International Students; Dementia Care; Research Leadership; Community Engagement; Educational Innovation.

Introduction

Benjamin Ajibade serves as Assistant Professor in Mental Health Nursing within the Department of Nursing, Midwifery and Health at Northumbria University. His career spans clinical nursing, healthcare management, academic leadership, teaching, research, and professional service. Throughout his career he has worked across multiple healthcare and higher education institutions in both Nigeria and the United Kingdom, contributing to nursing practice, professional development, educational innovation, and evidence-informed healthcare delivery.[1]

His academic interests encompass mental health nursing, public health, research methodologies, healthcare equity, educational transitions, student wellbeing, dementia care, and decolonisation of curricula. These themes are reflected in his scholarly outputs, funded projects, conference presentations, doctoral supervision activities, and leadership roles within national and international educational networks.[1]

Research Profile

Benjamin Ajibade completed a Professional Doctorate in Nursing at the University of Sunderland, where his doctoral thesis investigated sociocultural factors influencing Nigerian nursing students transitioning into UK higher education through the application of LEGO® Serious Play® methodology. This research established a foundation for subsequent scholarly work concerning international student experiences, belonging, educational transitions, and inclusive pedagogical practice.[2]

His research portfolio demonstrates engagement with mental health, educational equity, public health, ageing, dementia, healthcare access, minority ethnic experiences, postgraduate research participation, and anti-racist educational practices. He has also contributed to collaborative projects funded through national and institutional initiatives focused on inclusion, healthcare access, and postgraduate researcher development.[1]

  • Institutional Lead for the Pro:NE project.
  • Principal and co-investigator on multiple healthcare and educational research initiatives.
  • Supervisor of undergraduate, postgraduate, professional doctorate, and PhD research.
  • Contributor to equality, diversity, and inclusion scholarship.
  • Researcher in nursing education and international student transitions.

Research Contributions

A notable aspect of Benjamin Ajibade’s scholarly contribution is the application of innovative educational methodologies to investigate complex sociocultural experiences. His work using LEGO® Serious Play® methodology has explored student transitions, learning experiences, and inclusion within higher education settings. Such research has contributed to broader discussions concerning student engagement, belonging, and educational equity.[2]

His contributions also extend to healthcare service accessibility and health equity research. Publications addressing reproductive health access barriers, minority ethnic healthcare experiences, dementia care, and postgraduate research participation demonstrate an interdisciplinary approach that integrates education, nursing, and public health perspectives.[4]

  • Research on educational transitions among international nursing students.
  • Studies promoting inclusivity and decolonisation in nursing education.
  • Projects addressing healthcare access among minoritised communities.
  • Research leadership in postgraduate researcher development initiatives.
  • Development of evidence-informed educational practices and mentorship frameworks.

Publications

Benjamin Ajibade’s most cited publications examine patient-centred care planning, international nursing student transitions, and innovative LEGO® Serious Play® methodology, contributing to nursing education, inclusion, and healthcare access research.[2][3][4][5]

Ajibade’s publication record includes peer-reviewed journal articles, conference papers, preprints, educational research outputs, and collaborative healthcare studies. Several publications have addressed nursing practice, international education, healthcare access, and student wellbeing.[2][3][4]

Research Impact

The documented impact of Benjamin Ajibade’s work can be observed across research, teaching, supervision, policy engagement, and professional practice. His funded projects have supported work on healthcare inclusion, culturally responsive care, postgraduate researcher development, and educational equity. He has also supervised substantial numbers of undergraduate and postgraduate students and has contributed to doctoral supervision, examination, and mentoring activities.[1]

Beyond formal research outputs, his leadership within equality and diversity initiatives, editorial responsibilities, external examiner appointments, validation panels, and healthcare stakeholder collaborations demonstrates broader academic influence extending beyond institutional boundaries.[1]

Award Suitability

Benjamin Ajibade’s profile demonstrates multiple characteristics commonly associated with academic recognition for innovative research and educational leadership. These include sustained engagement with research-informed teaching, innovative methodological approaches, leadership of externally funded projects, commitment to equity and inclusion, doctoral supervision, international academic collaboration, and dissemination of scholarship through publications and conferences.[1]

His use of LEGO® Serious Play® methodology in higher education research, leadership of initiatives supporting minoritised postgraduate researchers, involvement in healthcare equity projects, and contributions to curriculum transformation collectively provide evidence of innovation and impact within nursing education and healthcare scholarship.[3][5]

Conclusion

Benjamin Ajibade represents a scholar-practitioner whose career integrates nursing practice, higher education leadership, inclusive pedagogy, research supervision, and interdisciplinary scholarship. His contributions to mental health nursing education, educational equity, healthcare inclusion, and international student research have established a record of professional achievement and academic service. The available evidence indicates a sustained commitment to advancing knowledge, supporting learners, and promoting equitable healthcare and educational environments, supporting consideration for recognition through the Innovative Research Award.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Benjamin Ajibade, Author ID 57355622100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57355622100
  2. Ajibade, B. (2021). Assessing the patient’s needs and planning effective care. British Journal of Nursing, 30(20), 1166-1171. DOI: https://doi.org/10.12968/bjon.2021.30.20.1166
  3. Ajibade, B.O., & Hayes, C. (2022). Using LEGO® Serious Play® Methodology in supporting Nigerian nursing students’ sociocultural transitions to UK higher education. Nurse Education Today, 119, 105582. DOI: https://doi.org/10.1016/j.nedt.2022.105582
  4. Ajibade, B., Oguguo, C., Ling, J., & Eberhardt, J. (2022). Recommendations for removing access barriers to effective sexual/reproductive health services for young people in South East Nigeria: A systematic review. International Journal of Sexual and Reproductive Health Care. https://research.tees.ac.uk/ws/portalfiles/portal/55499093/IJSRHC_5_137.pdf
  5. Ajibade, B.O., & Hayes, C. (2020). An insight into utilising LEGO® Serious Play® to explore international student transitions into a UK higher education institution. SAGE Publications Ltd. https://scholar.google.com/citations?user=MiIjB38AAAAJ&hl=en&oi=sra

Nathalie Ledee | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Nathalie Lédée
MatriceLAB Innove, France

Nathalie Lédée
Affiliation MatriceLAB Innove
Country France
Scopus ID 6603321197
Documents 94
Citations 3,407
h-index 33
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-3166-2643

Nathalie Lédée, M.D., Ph.D., affiliated with MatriceLAB Innove, France, is a physician-scientist whose work has contributed to the advancement of reproductive medicine, reproductive immunology, embryo implantation biology, and assisted reproductive technologies (ART). Her academic and professional career combines clinical leadership, translational research, biotechnology innovation, and scientific mentorship. She has served in senior research and healthcare leadership positions while maintaining an active publication record and developing patented technologies aimed at improving implantation success and fertility outcomes.[1][2]

Abstract

This article summarizes the academic, clinical, and scientific achievements of Nathalie Lédée, a French physician-scientist specializing in reproductive medicine and reproductive immunology. Her research has focused on understanding immune tolerance, cytokine regulation, embryo implantation mechanisms, and biomarker-guided fertility treatments. Through leadership roles in academia, healthcare institutions, and biotechnology innovation, she has contributed to translational approaches that connect laboratory discoveries with clinical reproductive care. Her scientific output, patents, and international collaborations have influenced contemporary research in embryo implantation and assisted reproduction.[1][3]

Keywords

Reproductive Medicine; Reproductive Immunology; Embryo Implantation; Assisted Reproductive Technology; IVF; Cytokines; Fertility Research; Translational Medicine; Biomarkers; Endometrial Immune Profiling; Clinical Research; Human Reproduction.

Introduction

Nathalie Lédée obtained her Doctor of Medicine degree from the University Paris VI in 1993, completed a Master of Science at McGill University in Canada in 1995, and earned a Ph.D. in reproductive immunology in 2003. Her academic development was complemented by clinical training in obstetrics, gynecology, and reproductive medicine. Throughout her career she has pursued the integration of fundamental immunological discoveries into practical fertility treatments and patient-centered reproductive care.[1]

Her professional activities have included appointments as assistant professor, senior investigator at INSERM research units, invited professor at the University of Liège, head of reproductive medicine centers, and president of MatriceLab Innove. These positions enabled her to contribute to multidisciplinary initiatives linking clinical medicine, biotechnology innovation, and translational research.[2]

Research Profile

Nathalie Lédée’s research centers on the immunological events occurring during embryo implantation and early pregnancy. Her investigations have examined maternal-fetal dialogue, cytokine regulation, immune tolerance, uterine receptivity, and biomarkers associated with reproductive success. She has emphasized translational methodologies designed to improve embryo selection, implantation outcomes, and personalized reproductive therapies.[3]

  • Reproductive Medicine and Fertility Care
  • Reproductive Immunology
  • Embryo Implantation Biology
  • Assisted Reproductive Technologies (ART)
  • Endometrial Immune Profiling
  • Biomarker Discovery and Validation
  • Cytokine Biology
  • Translational Clinical Research

Research Contributions

Among her recognized scientific contributions is the development of immune-based approaches for evaluating uterine receptivity and implantation potential. Her work has advanced understanding of how cytokine balance and local immune regulation influence successful embryo implantation and pregnancy outcomes.[3]

She is also inventor of patented technologies addressing embryo implantation and oocyte selection. These innovations seek to improve clinical decision-making within IVF and ART programs by introducing objective biological markers into reproductive treatment pathways.[4]

  • Patent PCT WO-2008/009705 involving granulocyte colony-stimulating factor (G-CSF) assessment in follicular fluid.
  • Patent PCT/EP2013/065355 concerning methods for increasing implantation success in assisted reproduction.
  • Leadership of translational fertility research programs connecting laboratory findings to patient care.
  • Contributions to European and international reproductive medicine networks.

Publications

Nathalie Lédée has authored influential studies in reproductive immunology and embryo implantation, including randomized trials on endometrial immune profiling and precision therapy that improved live birth outcomes after embryo transfer.[3] Her work further explored uterine immune profiling in assisted reproductive technology, advancing personalized fertility care.[4] Additional contributions include research on sperm microRNA expression and fertility biomarkers,[5] immune predictors of recurrent miscarriage and therapeutic outcomes,[6] and the role of interleukin-18 in predicting embryo transfer success.[7]

Research Impact

The research record of Nathalie Lédée includes 94 indexed documents, more than 3,407 citations, and an h-index of 33. These indicators reflect sustained scholarly engagement within reproductive medicine and reproductive immunology. Her publications have addressed clinically relevant challenges including implantation failure, recurrent miscarriage, immune biomarkers, and fertility treatment optimization.[1]

Her contributions have been recognized through competitive grants, scientific awards, international fellowships, leadership positions in European research initiatives, and memberships in major professional societies including ESHRE, the American Society of Reproductive Immunology, and European reproductive medicine organizations.[2]

Award Suitability

The nomination of Nathalie Lédée for the Innovative Research Award may be considered on the basis of her long-standing contributions to reproductive medicine, translational immunology, fertility innovation, and clinical leadership. Her work demonstrates a sustained commitment to developing evidence-based approaches that improve reproductive outcomes and expand scientific understanding of embryo implantation biology.[3][4]

Additional factors supporting recognition include internationally patented inventions, leadership in fertility centers, successful integration of biotechnology innovation into healthcare practice, and publication of influential research addressing major challenges in assisted reproduction.[4][5]

Conclusion

Nathalie Lédée has established a distinguished career at the intersection of clinical reproductive medicine, reproductive immunology, and translational biomedical innovation. Through academic research, leadership of fertility programs, biotechnology entrepreneurship, and development of novel diagnostic and therapeutic strategies, she has contributed to advancements in understanding and improving human reproduction. Her body of work represents a notable example of translational science applied to reproductive healthcare.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Nathalie Lédée, Author ID 6603321197. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6603321197
  2. ORCID. (n.d.). Nathalie Lédée – ORCID Research Profile. https://orcid.org/0000-0002-3166-2643
  3. Lédée, N., Petitbarat, M., Dray, G., Chevrier, L., Kazhalawi, A., Rahmati, M., et al. (2025). Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial. Frontiers in Immunology. DOI: https://doi.org/10.3389/fimmu.2025.1523871
  4. Lédée, N., Petitbarat, M., Prat-Ellenberg, L., Dray, G., Vaucoret, V., Kazhalawi, A., et al. (2023). The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance. International Journal of Molecular Sciences. https://www.mdpi.com/1422-0067/24/14/11322
  5. Cassuto, N.G., Lédée, N., Boitrelle, F., Mouik, H., Larue, L., Keromnes, G., et al. (2025). Genome-Wide microRNA Expression Profiling in Human Spermatozoa and Its Relation to Sperm Quality. Genes. https://www.mdpi.com/2073-4425/16/1/53
  6. Kolanska, K., Lédée, N., Dabi, Y., Dechartres, A., et al. (2021). Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. American Journal of Reproductive Immunology. https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13425
  7. Ledee-Bataille, N., Olivennes, F., Kadoch, J., Dubanchet, S., Frydman, N., Chaouat, G., & Frydman, R. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Human Reproduction. DOI: https://doi.org/10.1093/humrep/deh356

Saksham Kohli | Health Professions | Best Researcher Award

Best Researcher Award

Saksham Kohli
Cook County Health

Saksham Kohli
Affiliation Cook County Health
Country United States
Scopus ID 59495632900
Documents 52
Citations 4
Subject Area Health Professions
Event Top Teachers Awards
ORCID 0000-0001-6983-1804

The Best Researcher Award recognition highlights the scholarly activities and emerging research contributions of Saksham Kohli at Cook County Health. Working within the field of Health Professions, Saksham Kohli has contributed to studies involving gastroenterology, hepatology, nephrology, and healthcare outcomes research. Recent publications demonstrate engagement with evidence-based clinical investigations addressing inpatient outcomes, quality improvement methodologies, readmission patterns, and patient survival analyses.[1] Through interdisciplinary research and participation in contemporary clinical studies, Saksham Kohli has supported the advancement of knowledge relevant to healthcare quality, patient management, and population-level medical outcomes.[2]

Abstract

This article presents an academic overview of Saksham Kohli and the research profile associated with recognition under the Best Researcher Award category. The researcher’s recent scholarly output focuses on clinical outcomes, gastrointestinal diseases, healthcare quality assessment, and patient-centered investigations. Published studies have addressed metabolic dysfunction-associated liver disease, endoscopy performance evaluation, alcoholic hepatitis readmissions, and survival considerations among elderly dialysis patients.[2]

Keywords

Health Professions, Gastroenterology, Clinical Outcomes Research, Healthcare Quality Improvement, Hepatology, Readmission Studies, Evidence-Based Medicine.

Introduction

Healthcare research plays a significant role in improving clinical practice, patient outcomes, and healthcare system efficiency. Researchers working across medical specialties contribute to evidence generation that supports informed decision-making and policy development. Saksham Kohli’s published work reflects participation in studies examining disease burden, treatment outcomes, healthcare utilization, and quality improvement initiatives within contemporary clinical settings.[3]

Research Profile

Affiliated with Cook County Health in the United States, Saksham Kohli has developed a research profile centered on applied clinical investigations. Indexed under Scopus Author ID 59495632900, the researcher has contributed to publications spanning gastroenterology, hepatology, nephrology, and healthcare analytics. These studies demonstrate engagement with real-world healthcare datasets and outcome-oriented medical research.[1]

Research Contributions

The research contributions of Saksham Kohli include analyses of metabolic-dysfunction-associated steatotic liver disease and its impact on inpatient outcomes, assessments of endoscope tip angulation performance, nationwide evaluations of alcoholic hepatitis readmissions, and investigations involving elderly dialysis populations.[2] These studies contribute to clinical understanding by examining patient outcomes, healthcare quality metrics, and disease management strategies using quantitative methodologies.[4]

Publications

  • Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes.
  • Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
  • Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
  • Octogenarians on Dialysis; Navigating Survival Amidst Struggles.

Research Impact

The available publication record demonstrates contributions to clinically relevant topics affecting patient care and healthcare delivery. Research addressing liver disease outcomes, readmission risk factors, endoscopic performance, and nephrology-related survival outcomes provides useful evidence for healthcare professionals and researchers seeking to improve treatment effectiveness and quality standards.[5]

Award Suitability

Saksham Kohli’s profile aligns with the objectives of the Best Researcher Award through demonstrated scholarly engagement, publication activity, and contributions to healthcare research. The combination of outcome-based studies, quality improvement initiatives, and multidisciplinary clinical investigations reflects an active commitment to advancing medical knowledge and evidence-based practice.[1]

Conclusion

Saksham Kohli has contributed to a growing body of healthcare research through studies addressing important clinical and quality-of-care challenges. The published work demonstrates involvement in contemporary medical investigations and supports the dissemination of evidence relevant to patient outcomes, healthcare systems, and disease management. These accomplishments provide a foundation for recognition within academic and professional research communities.

References

  1. Elsevier. (n.d.). Scopus author details: Saksham Kohli, Author ID 59495632900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59495632900
  2. Kohli, S. et al. (2026). Impact of MASLD and MASH on Clostridioides difficile Inpatient Outcomes.
    https://doi.org/10.3390/gastroent17020038
  3. Kohli, S. et al. (2026). Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
    https://doi.org/10.1055/a-2877-9452
  4. Kohli, S. et al. (2026). Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
    https://doi.org/10.3390/gidisord8020027
  5. Kohli, S. et al. (2025). Octogenarians on Dialysis; Navigating Survival Amidst Struggles.
    https://doi.org/10.34172/jnp.2024.21476
  6. Top Teachers Awards. (n.d.). Best Researcher Award Recognition Program.
    topteachers.net

Zeynep Karaman Özlü | Nursing and Health Professions | Best Researcher Award

Best Researcher Award

Zeynep Karaman Özlü
Atatürk University, Türkiye
Zeynep Karaman Özlü
Affiliation Atatürk University
Country Turkey
Scopus ID 36677390200
Documents 40
Citations 480
h-index 11
Subject Area Nursing and Health Professions
Event Top Teachers Awards
ORCID 0000-0001-8896-5461
Google Scholar 9s_Dk3kAAAAJ

Zeynep Karaman Özlü is a Turkish nursing scholar, educator, administrator, and researcher affiliated with Atatürk University. Her academic career encompasses surgical nursing, perioperative care, patient safety, intensive care nursing, healthcare quality, accreditation, and emerging applications of artificial intelligence in healthcare. Through research, teaching, leadership activities, international collaborations, and scientific service contributions, she has developed a multidisciplinary academic profile recognized within nursing and health sciences communities.[1]

Abstract

This article summarizes the academic achievements, research activities, teaching contributions, leadership responsibilities, and scholarly impact of Professor Zeynep Karaman Özlü. Her work primarily focuses on surgical nursing, perioperative care, patient safety, healthcare quality, intensive care nursing, and evidence-based clinical practice. Her scholarly portfolio demonstrates continuous engagement in education, research, international collaboration, and healthcare innovation within nursing sciences.[1]

Keywords

Surgical Nursing, Perioperative Nursing, Patient Safety, Intensive Care Nursing, Nursing Education, Healthcare Quality, Accreditation, Clinical Research Nursing, Artificial Intelligence in Healthcare, Health Services Research.

Introduction

Professor Zeynep Karaman Özlü has served Atatürk University through academic, administrative, educational, and research-oriented roles. Beginning her academic progression as a research assistant and advancing to full professor, she has contributed to curriculum development, postgraduate supervision, institutional quality initiatives, accreditation processes, scientific evaluation activities, and international research networks. Her academic background includes master’s and doctoral studies in surgical nursing, forming the foundation for a sustained research career focused on improving healthcare outcomes and nursing practice.[1]

Research Profile

The research profile of Zeynep Karaman Özlü integrates clinical nursing research, healthcare quality management, patient-centered care, intensive care practice, surgical recovery, psychological adaptation, and healthcare innovation. She has participated in European COST Actions, contributed to multidisciplinary projects, reviewed national research proposals, and supported quality assurance initiatives within higher education and healthcare systems. Her research areas increasingly include digital transformation and artificial intelligence applications relevant to healthcare delivery and nursing education.[1]

Research Contributions

Research contributions include advancing perioperative nursing practice, improving postoperative patient care, validating clinical assessment instruments, investigating psychological resilience among healthcare professionals, evaluating anxiety management interventions, promoting patient safety frameworks, supporting healthcare quality accreditation, strengthening nursing education methodologies, integrating evidence-based practice into clinical environments, and encouraging responsible innovation in healthcare technologies.[1]

Publications

Selected publications demonstrate contributions to postoperative recovery, psychological adaptation, clinical measurement validation, patient well-being, and nursing assessment methodologies. These studies have addressed pain management, resilience during public health emergencies, surgical fear assessment, relaxation interventions, and sleep evaluation in clinical populations.[2][3][4][5][6]

  • Effect of music on postoperative pain and physiologic parameters of patients after open heart surgery.
  • The effect of the fear of COVID-19 on healthcare professionals’ psychological adjustment skills.
  • Validation of the Turkish version of the Surgical Fear Questionnaire.
  • Progressive muscle relaxation exercises and outcomes among patients with COVID-19.
  • Richard Campbell Sleep Scale validity and reliability study.

Research Impact

With 40 indexed documents, approximately 480 citations, and an h-index of 11, the scholarly record reflects measurable influence within nursing and health sciences literature. Research outputs have contributed to evidence-based nursing practice, clinical assessment, perioperative care improvement, psychological support strategies, and healthcare quality enhancement. Citation activity indicates continuing relevance across educational, clinical, and research settings.[1]

Award Suitability

The profile demonstrates qualifications commonly associated with academic recognition programs through sustained scholarly productivity, leadership in quality and accreditation initiatives, participation in international research collaborations, supervision and teaching across educational levels, scientific reviewing responsibilities, healthcare innovation activities, and documented research impact. These achievements collectively support consideration for recognition within research and higher education award frameworks.[1]

Conclusion

Zeynep Karaman Özlü represents an established academic contributor within nursing and health professions. Her record combines clinical research, educational leadership, quality assurance, international collaboration, and professional service. The breadth of activities documented across research, teaching, administration, and healthcare innovation illustrates a comprehensive academic career with continuing contributions to nursing science and healthcare improvement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zeynep Karaman Özlü, Author ID 36677390200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=36677390200
  2. Özer N., Özlü Z.K., Arslan S., Günes N. (2010). Effect of music on postoperative pain and physiologic parameters of patients after open heart surgery. Pain Management Nursing. https://doi.org/10.1016/j.pmn.2010.05.002
  3. Secer I., Ulaş S., Karaman-Özlü Z. (2020). The effect of the fear of COVID-19 on healthcare professionals’ psychological adjustment skills: mediating role of experiential avoidance and psychological resilience. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2020.561536
  4. Bağdigen M., Özlü Z.K. (2017). Validation of the Turkish version of the Surgical Fear Questionnaire. Journal of PeriAnesthesia Nursing. https://doi.org/10.1016/j.jopan.2017.05.007
  5. Özlü I., Öztürk Z., Karaman Özlü Z., Tekin E., Gür A. (2021). The effects of progressive muscle relaxation exercises on the anxiety and sleep quality of patients with COVID-19: A randomized controlled study. Perspectives in Psychiatric Care. https://doi.org/10.1111/ppc.12750
  6. Özlü Z.K., Özer N. Richard Campbell Sleep Scale Validity and Reliability Study. Journal of Turkish Sleep Medicine. 10.4274/jtsm.02.008

Timea Claudia Ghitea | Medicine and Health Sciences | Women Researcher Award

Women Researcher Award

Timea Claudia Ghitea
University of Oradea, Romania
Timea Claudia Ghitea
Affiliation University of Oradea
Country Romania
Scopus ID 57214826600
Documents 103
Citations 722
h-index 15
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0001-8981-1958
Google Scholar VsFBqbQAAAAJ

Timea Claudia Ghitea is a Romanian academic, pharmacist, nutrition specialist, and university educator affiliated with the Faculty of Medicine and Pharmacy at the University of Oradea. Her scholarly activities integrate clinical nutrition, metabolic disorders, dietetics, rehabilitation medicine, pharmaceutical sciences, and public health research. Through academic teaching, clinical practice, and scientific publication, she has contributed to advancing evidence-based nutritional interventions and multidisciplinary healthcare approaches. Her research profile demonstrates sustained engagement in metabolic syndrome, diabetes, probiotics, sarcopenia, rehabilitation outcomes, and maternal health studies.[1][2]

Abstract

This article summarizes the academic achievements, professional experience, research output, and scientific impact of Timea Claudia Ghitea. Her work spans medicine, pharmacy, nutrition science, and metabolic health, with particular emphasis on evidence-based dietary interventions and patient-centered healthcare. Through extensive publication activity and interdisciplinary collaboration, she has contributed to contemporary understanding of chronic disease management, rehabilitation nutrition, and probiotic-based therapeutic approaches.[1]

Keywords

Clinical Nutrition, Dietetics, Metabolic Syndrome, Diabetes Mellitus, Probiotics, Sarcopenia, Rehabilitation Medicine, Pharmacy, Biomedical Sciences, Public Health, Farmacie, Nutriție, Stiinte Biomedicale, Microbiommi, Microbiologie, General & Internal Medicine, Research & Experimental Medicine, Biochemistry & Molecular Biology, Health Care Sciences & Services, Nutrition & Dietetics.

Introduction

Timea Claudia Ghitea has developed a multidisciplinary career combining pharmaceutical practice, academic instruction, nutrition consultancy, and biomedical research. Since 2017 she has served as University Assistant at the Faculty of Medicine and Pharmacy, University of Oradea, while simultaneously practicing as a clinical and sports nutritionist. Her educational background includes degrees in biology, chemistry, pharmacy, cell biology, and a PhD in Biomedical Sciences with specialization in clinical and sports nutrition, providing a comprehensive foundation for translational healthcare research.[1]

Research Profile

The research profile of Timea Claudia Ghitea reflects sustained scholarly productivity in medicine and health sciences, supported by more than one hundred indexed publications, substantial citation activity, and an established h-index. Her investigations focus on nutrition-related interventions, metabolic disorders, gastrointestinal microbiota, pharmaceutical sciences, rehabilitation outcomes, and clinical management strategies for chronic diseases. The interdisciplinary nature of her work facilitates collaboration among physicians, pharmacists, nutritionists, and public health researchers.[1][2]

Research Contributions

  • Advanced understanding of probiotic and prebiotic applications in metabolic syndrome and type 2 diabetes management.[3]
  • Contributed to evidence regarding nutritional therapy for sarcopenia associated with immobilization and chronic disease conditions.[6]
  • Investigated dietary intervention strategies influencing sarcopenic indicators among patients with metabolic syndrome.[7]
  • Supported multidisciplinary studies examining rehabilitation outcomes and prevention of secondary complications following spinal cord injury.[5]
  • Participated in comprehensive reviews addressing maternal health and antiphospholipid syndrome during pregnancy.[4]

Publications

Notable publications include research on gut microbiota and metabolic disease, pregnancy-related autoimmune disorders, rehabilitation medicine, nutrition-based interventions for sarcopenia, and metabolic syndrome management. These studies collectively demonstrate a commitment to translational healthcare research with practical clinical applications.[3][4][5][6][7]

  1. Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium.
  2. Antiphospholipid Syndrome in Pregnancy: A Comprehensive Literature Review.
  3. The Outcomes of Robotic Rehabilitation Assisted Devices Following Spinal Cord Injury and the Prevention of Secondary Associated Complications.
  4. The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic.
  5. The Influence of Diet Therapeutic Intervention on the Sarcopenic Index of Patients with Metabolic Syndrome.

Research Impact

With 103 indexed documents, 722 citations, and an h-index of 15, Timea Claudia Ghitea has established a measurable academic presence within medicine and health sciences. Her publications have contributed to contemporary discussions regarding nutrition-based therapeutic approaches, metabolic disease management, rehabilitation medicine, and clinical healthcare optimization. The citation performance of her work indicates ongoing scholarly engagement and relevance within multiple biomedical disciplines.[1]

Award Suitability

Timea Claudia Ghitea demonstrates several characteristics commonly associated with recognition through a Women Researcher Award. These include sustained publication productivity, interdisciplinary scientific contributions, active involvement in academic teaching, leadership in healthcare practice, mentorship activities, professional society memberships, and research addressing significant public health challenges. Her integration of clinical practice and academic scholarship illustrates a model of translational research with practical societal relevance.[1][2]

Conclusion

Timea Claudia Ghitea has built a distinguished academic and professional career spanning pharmacy, nutrition, medicine, and health sciences. Her research contributions, publication record, educational achievements, and clinical expertise collectively demonstrate a sustained commitment to advancing evidence-based healthcare. These accomplishments support her profile as a noteworthy contributor to biomedical research and higher education.

References

  1. Elsevier. (n.d.). Scopus author details: Timea Claudia Ghitea, Author ID 57214826600. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57214826600
  2. ORCID. (n.d.). Timea Claudia Ghitea researcher profile. https://orcid.org/0000-0001-8981-1958
  3. TC Ghitea et al. Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium. Microorganisms. https://doi.org/10.3390/microorganisms9030618
  4. TC Ghitea et al. Antiphospholipid Syndrome in Pregnancy: A Comprehensive Literature Review. BMC Pregnancy and Childbirth. https://link.springer.com/article/10.1186/s12884-025-07471-w
  5. TC Ghitea et al. The Outcomes of Robotic Rehabilitation Assisted Devices Following Spinal Cord Injury and the Prevention of Secondary Associated Complications. Medicina. https://doi.org/10.3390/medicina58101447
  6. TC Ghitea et al. The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic. Nutrients. https://doi.org/10.3390/nu14214701
  7. Ghitea TC et al. The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome. Acta Endocrinologica. https://pmc.ncbi.nlm.nih.gov/articles/PMC8126402/

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Dr. Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Aristotle University of Thessaloniki | Greece

Dr. Stylianos Bourmpoutelis is an emerging researcher in Internal Medicine whose work is strongly centered on HIV medicine, antimicrobial resistance, and the clinical–microbiological interfaces shaping modern infectious disease care. His research activity reflects a sustained commitment to improving patient outcomes through evidence-based clinical strategies, with particular emphasis on vulnerable populations such as people who inject drugs. His contributions include data collection, clinical evaluation, and outcome-driven analysis that support impactful publications in peer-reviewed journals. Bourmpoutelis has participated in multidisciplinary research networks, contributing to studies that integrate public health, infectious diseases, and microbiology in order to optimize care pathways and improve treatment adherence. His scholarly visibility continues to grow through citations in reputable databases and the ongoing expansion of his indexed publications. He maintains active research profiles and consistently updates citation-related documents to ensure transparency and accessibility for the scientific community. Current citation metrics include an estimated Scopus h-index of 2 and a Google Scholar h-index of 3, reflecting the early yet steadily increasing influence of his work. His documented contributions demonstrate strong methodological engagement, rigorous data interpretation, and a readiness to collaborate across clinical and scientific teams. Bourmpoutelis’s research record aligns with the ideals of the Young Scientist Award, showcasing innovation, academic promise, and meaningful contributions to public health research. His scientific outputs emphasize integrated care models, real-world clinical outcomes, and microbiological investigations that collectively advance understanding within internal medicine and infectious disease research. With a growing portfolio of indexed publications and documented research contributions, he continues to establish himself as a dedicated early-career scientist advancing impactful, ethically grounded, and methodologically robust medical research.

Publication Profile

Google Scholar

Featured Publications

Roussos, S., Protopapapas, K., Mastrogianni, E., Totsikas, C., Moschopoulos, C. D., Bourmpoutelis, S., Resta, P., Procter, K., Kokolesis, E., Antoniadou, A., et al. (2025). Rapid ART initiation with BIC/FTC/TAF in people who inject drugs in Greece: Results from a pilot single-arm study of an integrated care model. Microorganisms, 13(12), 2697.

Arriel Makembi Bunkete | Health Professions | Best Researcher Award

Dr. Arriel Makembi Bunkete | Health Professions | Best Researcher Award

University of Kinshasa | Congo, Democratic Republic of the

Dr. Arriel Makembi Bunkete is a dedicated nephrologist and internal medicine specialist whose clinical and scientific work focuses on kidney transplantation, dialysis innovations, and the epidemiology of chronic kidney disease across diverse and resource-limited settings. He has developed a strong research identity through his contributions to transplant coordination, acute and chronic dialysis strategies, extracorporeal purification techniques, clinical nephrology, glomerular diseases, and the management of toxicological and environmental kidney injuries. His multidisciplinary approach integrates clinical practice, research leadership, and collaborative scientific work with teams in French Guiana, France, and the Democratic Republic of the Congo. Dr. Bunkete’s research addresses critical challenges such as anemia in kidney transplant recipients, sickle cell nephropathy, lupus nephritis activity, paraquat poisoning, high blood lead levels in dialysis patients, and the implementation of home hemodialysis in remote territories. His scientific output includes peer-reviewed articles, case reports, international conference abstracts, and involvement in ongoing epidemiological studies. Recognized for his growing academic influence, he has accumulated 4 citations, an h-index of 1, and an i10-index of 0 (Google Scholar metrics), with comparable citation performance indexed in Scopus. He also contributes as a reviewer for leading nephrology journals, reflecting his commitment to advancing global renal research. His work has received competitive research grant support for studies on APOL1 variants and chronic kidney disease in French Guiana, reinforcing his standing as an emerging investigator in tropical nephrology and transplant medicine. With a strong scientific footprint, ongoing research leadership, and steady scholarly growth, Dr. Bunkete demonstrates the qualities associated with the Best Researcher Award in nephrology.

Publication Profile

Google Scholar

Featured Publications

Bunkete, A. M. (2025). Home hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities. Bulletin de la Dialyse à Domicile, 8(2), 107–111.

Kabasele, D. B., Bunkete, A. M., Mbayabo, G., Lumbala, P., Matondo, O., Aloni, M., et al. (2025). Hydroxyurea and regression of sickle cell nephropathy: Open clinical trial in a pediatric population in DR Congo. Kidney360.

Bunkete, A. M., Kasonga, P. K., Fermigier, F., & Djiconkpode, I. (2025). WCN25-137: Pediatric nephrology in French Guiana – Overview and outlook. Kidney International Reports, 10(2), S615.

Anga, K., Makembi, A., Amisi, É., Delpierre, É., Ha, V. H. T., Mbombo, W., et al. (2024). Morbidity and mortality of acute renal failure in COVID-19 patients in intensive care according to waves/variant: Case of the Grand Hôpital de l’Est Francilien site de Meaux. Open Journal of Internal Medicine, 14(1), 16–29.

Bunkete, A. M., Belgrine, M., Sidibe, M., Bellony, S., Davodun, T., Djiconkpode, I., et al. (2025). Dialyse péritonéale chez un nourrisson avec insuffisance rénale aiguë sévère: Dialyse réalisée en plein vol lors d’une évacuation sanitaire en Guyane – À propos d’un cas. Bulletin de la Dialyse à Domicile, 8(3), 255–261.

Liu Wenyi | Health Sciences | Best Researcher Award

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.